AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

About this update from Abcellera Biologics Inc.

VANCOUVER, British Columbia --(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) will announce its third quarter 2025 financial results on Thursday, November 6, 2025 , and hold an earnings conference call at 2:00 p.m. Pacific Time ( 5:00 p.m. Eastern Time ) the same day. A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website . A replay will be available through the same link following the conference call. About AbCellera Biologics Inc. AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20250929862522/en/ Inquiries Media: Tiffany Chiu ; [email protected] , +1(236)521-6774 Business Development: Murray McCutcheon , Ph.D.; [email protected] , +1(604)559-9005 Investor Relations: Peter Ahn ; [email protected] , +1(778)729-9116 Source: AbCellera Biologics Inc.

View stock analysis, news, and events for Abcellera Biologics Inc.